性传播疾病的流行对人类健康和社会发展构成了严重威胁，其有效防治是各个国家共同面临的难题。统一、规范的诊断和治疗指南将对性传播疾病的防治起到关键性作用。2015年6月，美国疾病控制中心在《Morbidity and Mortality Weekly Repo...性传播疾病的流行对人类健康和社会发展构成了严重威胁，其有效防治是各个国家共同面临的难题。统一、规范的诊断和治疗指南将对性传播疾病的防治起到关键性作用。2015年6月，美国疾病控制中心在《Morbidity and Mortality Weekly Repot》上刊登了2015版性传播疾病诊断和治疗指南，对阴道感染、盆腔炎、淋病、沙眼衣原体感染等多个性传播疾病的诊断和治疗指南进行了更新和完善，这对性传播疾病的进一步防治具有重要意义，同时对我国性传播疾病的诊断和治疗也具有重大参考意义。为此，本刊第一时间邀请北京大学深圳医院樊尚荣教授对其进行了翻译和解读。本刊2015年第18卷第25—29期，连续刊登阴道感染、淋病、沙眼衣原体感染、生殖器疱疹、梅毒、盆腔炎、人乳头瘤病毒感染、性侵犯／虐待受害者性传播疾病的诊断和治疗指南，本期总结2015年性传播疾病诊断和治疗指南的更新内容，解读指南更新的要点，为临床医生的运用提供依据。展开更多
The Centers for Disease Control and Prevention (CDC) is publishing a document titled "Good Laboratory Practices for Molecular Genetic Testing for Heritable Diseases and Conditions" in the recommendations a...The Centers for Disease Control and Prevention (CDC) is publishing a document titled "Good Laboratory Practices for Molecular Genetic Testing for Heritable Diseases and Conditions" in the recommendations and reports series of the Morbidity and Mortality Weekly Report (MMWR) in spring 2009. This document will provide the recommendations of the Clinical Laboratory Improvement Advisory Committee (CLIAC) for good laboratory practices in the areas of molecular genetic testing that have been recognized as needing specific guidance for complying with applicable requirements in the Clinical Laboratory Improvement Amendments (CLIA) regulations,or as needing quality assurance measures in addition to the general CLIA requirements. The MMWR document is intended to be used by the following laboratories or individuals for the purpose of improving the quality and utilization of genetic laboratory services:(1)Laboratories performing molecular genetic testing for heritable diseases and conditions; (2)Users of the laboratory services,including (but not limited to) healthcare professionals,patients,referring or referral laboratories,and payers of laboratory services; (3)Medical and public health professionals who evaluate laboratory practices and policies.展开更多
文摘性传播疾病的流行对人类健康和社会发展构成了严重威胁，其有效防治是各个国家共同面临的难题。统一、规范的诊断和治疗指南将对性传播疾病的防治起到关键性作用。2015年6月，美国疾病控制中心在《Morbidity and Mortality Weekly Repot》上刊登了2015版性传播疾病诊断和治疗指南，对阴道感染、盆腔炎、淋病、沙眼衣原体感染等多个性传播疾病的诊断和治疗指南进行了更新和完善，这对性传播疾病的进一步防治具有重要意义，同时对我国性传播疾病的诊断和治疗也具有重大参考意义。为此，本刊第一时间邀请北京大学深圳医院樊尚荣教授对其进行了翻译和解读。本刊2015年第18卷第25—29期，连续刊登阴道感染、淋病、沙眼衣原体感染、生殖器疱疹、梅毒、盆腔炎、人乳头瘤病毒感染、性侵犯／虐待受害者性传播疾病的诊断和治疗指南，本期总结2015年性传播疾病诊断和治疗指南的更新内容，解读指南更新的要点，为临床医生的运用提供依据。
文摘The Centers for Disease Control and Prevention (CDC) is publishing a document titled "Good Laboratory Practices for Molecular Genetic Testing for Heritable Diseases and Conditions" in the recommendations and reports series of the Morbidity and Mortality Weekly Report (MMWR) in spring 2009. This document will provide the recommendations of the Clinical Laboratory Improvement Advisory Committee (CLIAC) for good laboratory practices in the areas of molecular genetic testing that have been recognized as needing specific guidance for complying with applicable requirements in the Clinical Laboratory Improvement Amendments (CLIA) regulations,or as needing quality assurance measures in addition to the general CLIA requirements. The MMWR document is intended to be used by the following laboratories or individuals for the purpose of improving the quality and utilization of genetic laboratory services:(1)Laboratories performing molecular genetic testing for heritable diseases and conditions; (2)Users of the laboratory services,including (but not limited to) healthcare professionals,patients,referring or referral laboratories,and payers of laboratory services; (3)Medical and public health professionals who evaluate laboratory practices and policies.
